概括
莱维体痴呆症 (LBD),包括帕金森病痴呆症和莱维体痴呆症,是一种常见的神经退行性疾病. 通过了解关键特征和生物标志物的早期识别对于及时诊断和治疗至关重要.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 老年病的医生 老年病的医生
背景情况:
- 莱维体痴呆症 (LBD) 是帕金森病痴呆症 (PDD) 和莱维体痴呆症 (DLB) 的总称.
- 它是神经退行性痴呆的第二大常见原因,在临床实践中经常被忽视.
- 延迟诊断和治疗LBD增加了患者和护理人员的负担.
研究的目的:
- 审查LBD的流行病学,临床,认知,行为和生物标志物特征.
- 讨论目前LBD的治疗选择.
- 突出早期检测的重要性以及生物标志物在改善LBD识别中的作用.
主要方法:
- 关于莱维体痴呆症的当前文献的综述.
- 对PDD和DLB的诊断标准和预发症阶段的分析.
- 检查用于LBD诊断的指示性和发展性生物标志物.
主要成果:
- 指示性生物标志物包括多巴胺和诺亚激素系统的SPECT成像,以及多重睡眠学.
- 各种体液和成像中的α-Synuclein生物标志物正在开发中.
- 已出版的诊断标准和PDD和DLB的上下文化前发症阶段存在.
结论:
- 了解LBD的关键特征和利用生物标志物可以提高诊断准确性和及时性.
- 较早发现LBD有助于新疗法开发和临床试验招生.
- 基于蛋白质聚合的综合分期系统可能会促进LBD研究.
更多相关视频
12:28Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
17.3K
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
7.8K
相关概念视频
Dementia
96
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
96
Parkinson's Disease: Overview
479
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
479
Alzheimer's Disease: Overview
447
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
447
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Parkinson's Disease: Treatment
219
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
219
